BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19031946)

  • 21. Lymphangiogenesis in malignant tumours: Does it occur?
    Clarijs R; Ruiter DJ; de Waal RM
    J Pathol; 2001 Feb; 193(2):143-6. PubMed ID: 11180158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blocking neuropilin-2 function inhibits tumor cell metastasis.
    Caunt M; Mak J; Liang WC; Stawicki S; Pan Q; Tong RK; Kowalski J; Ho C; Reslan HB; Ross J; Berry L; Kasman I; Zlot C; Cheng Z; Le Couter J; Filvaroff EH; Plowman G; Peale F; French D; Carano R; Koch AW; Wu Y; Watts RJ; Tessier-Lavigne M; Bagri A
    Cancer Cell; 2008 Apr; 13(4):331-42. PubMed ID: 18394556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
    Issa A; Le TX; Shoushtari AN; Shields JD; Swartz MA
    Cancer Res; 2009 Jan; 69(1):349-57. PubMed ID: 19118020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Podoplanin expression in fibrous histiocytomas and cellular neurothekeomas.
    Kaddu S; Leinweber B
    Am J Dermatopathol; 2009 Apr; 31(2):137-9. PubMed ID: 19318798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical expression of podoplanin (D2-40), lymphangiogenesis, and neoangiogenesis in tooth germ, ameloblastomas, and ameloblastic carcinomas.
    Sánchez-Romero C; Bologna-Molina R; Mosqueda-Taylor A; de Almeida OP
    J Oral Pathol Med; 2017 Sep; 46(8):618-624. PubMed ID: 27859616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Identification of the novel platelet activation receptor CLEC-2 and Its pathological and physiological roles].
    Suzuki Inoue K; Inoue O; Ozaki Y
    Rinsho Byori; 2010 Dec; 58(12):1193-202. PubMed ID: 21348239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of lymphangiogenesis in cancer.
    Sundar SS; Ganesan TS
    J Clin Oncol; 2007 Sep; 25(27):4298-307. PubMed ID: 17878481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix.
    Ji RC
    Lymphat Res Biol; 2006; 4(2):83-100. PubMed ID: 16808670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Podoplanin: a novel diagnostic immunohistochemical marker.
    Ordóñez NG
    Adv Anat Pathol; 2006 Mar; 13(2):83-8. PubMed ID: 16670463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma.
    Filho AL; Baltazar F; Bedrossian C; Michael C; Schmitt FC
    Diagn Cytopathol; 2007 Dec; 35(12):786-91. PubMed ID: 18008346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular heterogeneity of tumor endothelium.
    Aird WC
    Cell Tissue Res; 2009 Jan; 335(1):271-81. PubMed ID: 18726119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma.
    Zhang B; Wang J; Gao J; Guo Y; Chen X; Wang B; Gao J; Rao Z; Chen Z
    J Cell Biochem; 2009 May; 107(1):134-43. PubMed ID: 19241443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors.
    Yu H; Gibson JA; Pinkus GS; Hornick JL
    Am J Clin Pathol; 2007 Nov; 128(5):776-82. PubMed ID: 17951199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of angiogenesis inhibitors in human bladder cancer may explain rapid metastatic progression after radical cystectomy.
    Beecken WD; Engl T; Jonas D; Blaheta RA
    Int J Mol Med; 2009 Feb; 23(2):261-6. PubMed ID: 19148551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of podoplanin expression in cancer-associated fibroblasts: a comprehensive review.
    Pula B; Witkiewicz W; Dziegiel P; Podhorska-Okolow M
    Int J Oncol; 2013 Jun; 42(6):1849-57. PubMed ID: 23588876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of podoplanin by transforming growth factor-beta in human fibrosarcoma.
    Suzuki H; Kato Y; Kaneko MK; Okita Y; Narimatsu H; Kato M
    FEBS Lett; 2008 Jan; 582(2):341-5. PubMed ID: 18158922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin.
    Liang H; Wu H; Giorgadze TA; Sariya D; Bellucci KS; Veerappan R; Liegl B; Acs G; Elenitsas R; Shukla S; Youngberg GA; Coogan PS; Pasha T; Zhang PJ; Xu X
    Am J Surg Pathol; 2007 Feb; 31(2):304-10. PubMed ID: 17255777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of podoplanin expression in squamous cell carcinoma of upper aerodigestive tract.
    Chuang WY; Chang YS; Yeh CJ; Wu YC; Hsueh C
    Histol Histopathol; 2013 Mar; 28(3):293-9. PubMed ID: 23348382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors.
    Schacht V; Dadras SS; Johnson LA; Jackson DG; Hong YK; Detmar M
    Am J Pathol; 2005 Mar; 166(3):913-21. PubMed ID: 15743802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.